Follicum strengthens its clinical expertise in diabetes as novel peptide candidate approaches clinic – establishes Scientific Advisory Board

Follicum AB today announces the establishment of a Scientific Advisory Board in the diabetes field. The purpose is to strengthen knowledge transfer from academic research to clinical application and commercialization. The Board consists of 5 internationally reputable experts with extensive experience in research into diabetes and its complications.
– By setting up a Scientific Advisory Board, we strengthen the company’s competence and clinical expertise, which is important both for quality assurance of our drug development within the diabetes complications area and for attracting large

Source: Follicum strengthens its clinical expertise in diabetes as novel peptide candidate approaches clinic – establishes Scientific Advisory Board

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.